Microsure wins CE mark for microsurgical robot, names new CEO
May 7, 2026
Microsure announced today that it received CE mark approval for its MUSA-3 surgical robot and named Alex Joseph as CEO.
Microsure announced today that it received CE mark approval for its MUSA-3 surgical robot and named Alex Joseph as CEO.
In a finding that challenges decades of assumptions about blood cancer, an international research team has shown for the first time that a specific subtype of diffuse large B cell lymphoma (DLBCL), which is the most common blood cancer in adults, is dramatically more lethal in women than in men.
A finger prick blood test combined with online brain testing—all done from home—could one day effectively identify people’s risk of developing dementia, according to a new study.
When the human heart is damaged by a heart attack, stiff scar tissue eventually forms around the affected areas. This weakens the heart’s pumping ability and increases the risk of heart failure and arrhythmias. Zebrafish, by contrast, can regenerate their hearts completely.
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology analysis to give pathologists “super vision” to detect hidden genetic markers of cancer in standard patient tissue samples.
A simple blood test can reveal the geographic relationships among healthy cells surrounding a cancerous tumor, researchers at Stanford Medicine and the Mayo Clinic have found. The test is the first noninvasive way to study what’s called the tumor microenvironment, which plays a critical role in determining how different patients—even those with similar tumors—fare after diagnosis and treatment.
New multiplexed imaging technology using standard clinical MRI systems can simultaneously map more than 20 biomarkers in high resolution, providing a comprehensive view of the brain with a single scan.
Sweden-based Multi4 Medical has received CE mark approval for its Multi4 System, an all-in-one endoscopic instrument designed to enable bladder cancer treatment during the same outpatient visit when cancer is detected.
Together, these announcements represent a step forward in increasing accessibility to complex DNA
More than half a billion people worldwide are living with diabetes, the vast majority with type 2 diabetes (T2D), a chronic condition that continues to rise alongside aging populations and changing lifestyles. Despite its prevalence, the cell-type-specific mechanisms that shape beta-cell adaptation and failure over time have remained only partially understood.